BioSpace News Archive

Over the last three years the STAR4BBI project has studied policy and standardisation hurdles that bio-based industries face. During the recent stakeholders’ workshop in Cologne, a set of seven measures to achieve better policies and standards for bio-based industries had been concluded.

Polarean Imaging plc (AIM: POLX), the clinical stage medical-imaging technology company, with a proprietary drug-device combination product for the visualisation of pulmonary function in the magnetic resonance imaging (MRI) market, announces a further update regarding the Company’s Phase III Clinical Trials (the “Clinical Trials”), following the Company’s announcement of 13 May 2019.

American Jewish Committee is urging Seattle leaders to condemn anti-Semitic threats against Ari Hoffman, a candidate for city council, and initiate steps to identify and prosecute those responsible for these hate crimes.

IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions, is pleased to announce the first Flash irradiation in an IBA Proteus®ONE compact gantry treatment room at the Rutherford Cancer Centre Thames Valley in Reading, United Kingdom, on June 8, 2019.

Digital Science has today launched a report on the state of open access monographs. The report addresses the question of how we integrate and value monographs in the increasingly open digital scholarly network.

Hygiena, a Warburg Pincus portfolio company specializing in rapid microbial detection, monitoring, and identification solutions, introduced the new EnSURE™ Touch Monitoring System. The EnSURE Touch is a next-generation monitoring system that collects, analyzes and reports data from multiple quality tests such as ATP, microorganisms, and enzymes, providing necessary data for audit and risk management.

Trial to Study Treatment of Peripheral Artery Disease with Orbital Atherectomy via Radial Access

SAGA Diagnostics AB, a precision oncology genomics testing company focused on ultrasensitive monitoring of cancer patients using blood samples and other liquid biopsies and tissues, today announces the raising of SEK 40 million in venture-backed financing (circa EUR 3.7 million, USD 4.1 million)

ACell, Inc. announced that it has reached final settlement agreements with the United States Attorney’s Office for the District of Maryland and three states to resolve all civil and criminal allegations relating to the sales and marketing of the Company’s products.

Point3 Farma, a vertically integrated large-scale supplier of CBD distillate and isolate, based in Center, Colorado has announced its Vice President, Biosciences and Plant Genetics, Joe Butler, will speak on the panel, “Flower, Seed, and Stalk: Finding the Right Cultivar For Your Hemp Business,” at the Hemp Industry Daily Conference, June 13.